Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Intangibles (2023 - 2026)

Treace Medical Concepts filings provide 3 years of Intangibles readings, the most recent being $7.1 million for Q4 2025.

  • On a quarterly basis, Intangibles fell 11.76% to $7.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.1 million, a 11.76% decrease, with the full-year FY2025 number at $7.1 million, down 11.76% from a year prior.
  • Intangibles hit $7.1 million in Q4 2025 for Treace Medical Concepts, down from $7.4 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $9.5 million in Q2 2023 to a low of $7.1 million in Q4 2025.
  • Median Intangibles over the past 3 years was $8.3 million (2024), compared with a mean of $8.3 million.
  • Biggest five-year swings in Intangibles: fell 10.0% in 2024 and later decreased 11.76% in 2025.
  • Treace Medical Concepts' Intangibles stood at $9.0 million in 2023, then decreased by 10.53% to $8.1 million in 2024, then fell by 11.76% to $7.1 million in 2025.
  • The last three reported values for Intangibles were $7.1 million (Q4 2025), $7.4 million (Q3 2025), and $7.6 million (Q2 2025) per Business Quant data.